DMT and Ayahuasca

Why DMT and ayahuasca are not addictive, how they differ in duration, and the serious MAOI drug interaction that makes mixing ayahuasca with antidepressants dangerous.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What DMT and Ayahuasca Are

DMT (N,N-dimethyltryptamine) is an intensely powerful, short-acting psychedelic, while ayahuasca is a traditional Amazonian brew that delivers the same molecule in a slow, hours-long form. Both are classic psychedelics, and like psilocybin and LSD, they are not physically addictive and carry a low potential for dependence[1]. The honest risks lie elsewhere, and ayahuasca in particular carries one serious, often-overlooked danger: a drug interaction that can become a medical emergency.

Fast Facts on DMT and Ayahuasca
  • DMT and ayahuasca are not physically addictive — as classic psychedelics, they don’t drive compulsive use or a withdrawal syndrome.
  • Ayahuasca’s biggest hidden danger is a drug interaction — it contains MAO inhibitors that can clash dangerously with antidepressants and certain foods, risking serotonin syndrome.
  • Smoked DMT is extremely brief while ayahuasca lasts hours — smoked DMT peaks within two minutes and fades by 30, while ayahuasca’s effects build over hours.

Why Neither Is Addictive

Said simplyNeither DMT nor ayahuasca hooks your body, there’s no craving, no withdrawal, no escalating use. Regular ayahuasca drinkers studied with clinical tools don’t look like people with a drug problem. The risks worth respecting are about the experience and, with ayahuasca, a specific drug interaction.

The fear that ayahuasca or DMT might be addictive runs into the same wall as it does with other classic psychedelics: the pharmacology and the real-world data point the other way.

They don’t produce dependence or a withdrawal syndrome. A systematic review of psychedelic harms places classic psychedelics, the DMT family included, at the low end of abuse liability, without the compulsive, escalating use that defines addiction[1]. There’s no craving cycle and no physical withdrawal.

The real-world evidence on ayahuasca is unusually strong. Researchers formally assessed addiction severity in regular ritual ayahuasca users using a standard clinical tool and compared them to non-users. The ayahuasca users did not show the medical and psychosocial harms typically associated with drugs of abuse; in fact they scored lower than controls on alcohol use and psychiatric problems, and many had stopped using other illicit drugs[2]. People who drink ayahuasca regularly, often weekly in a religious context, simply don’t develop the profile of addiction.

DMT’s nature works against habit, too. Smoked or injected DMT is so brief and so overwhelming that it doesn’t lend itself to casual, repeated use the way an addictive drug does. The experience is intense and complete, then over, with no pull to immediately redose.

How DMT and Ayahuasca Differ

They deliver the same molecule but feel like completely different experiences, and the reason is a clever bit of chemistry.

Smoked or injected DMT is the briefest profound experience in psychedelics. In controlled research, intravenous DMT produced peak blood levels and peak subjective effects within two minutes, with effects negligible by 30 minutes[3]. People describe being launched into and back out of an overwhelming alternate reality in the span of a short break. The intensity is extreme; the duration is tiny.

Ayahuasca stretches the same molecule across hours. On its own, DMT is broken down in the gut and has almost no effect when swallowed. Ayahuasca solves this by combining DMT-containing plants with plants rich in MAO inhibitors (beta-carbolines like harmine), which block the enzyme that would otherwise destroy the DMT[4]. In controlled study, ayahuasca’s effects peaked between 1.5 and 2 hours and unfolded as a long, immersive experience rather than DMT’s brief blast[4]. That same MAO inhibition, the thing that makes ayahuasca work, is also the source of its most serious danger.

Did you know?

According to research, DMT is found naturally in the human body and in many plants, which is part of why it’s sometimes called “the spirit molecule”[3]. Its presence in mammalian biology is real, though what it does there remains an open scientific question.

The Ayahuasca Danger That Deserves a Warning Label

Do not mix ayahuasca with antidepressantsIf you take an SSRI, SNRI, MAOI, or other serotonergic medication, combining it with ayahuasca can trigger serotonin syndrome, a life-threatening emergency. This is not a minor caution. Agitation, high fever, muscle rigidity, a racing heart, or confusion after ayahuasca means call 911.

This is the most important practical section on this page, because it’s the risk most likely to cause a true medical emergency, and it’s specific to ayahuasca’s chemistry.

The MAO inhibitors in ayahuasca interact dangerously with many drugs and some foods. Because ayahuasca contains MAO-inhibiting compounds, combining it with substances that raise serotonin, especially antidepressants like SSRIs and SNRIs, certain other psychiatric medications, and some recreational drugs, can push serotonin to dangerous levels[4]. The result can be serotonin syndrome, a potentially life-threatening reaction marked by agitation, racing heart, high fever, muscle rigidity, and confusion. This is a 911 emergency.

This interaction is why mixing ayahuasca with antidepressants is genuinely hazardous. Many people drawn to ayahuasca are also taking antidepressants, which makes this warning urgent rather than theoretical. Traditional MAOI dietary cautions can also apply. The practical message: ayahuasca is not something to combine with psychiatric medication or other serotonergic drugs without medical guidance, and the stakes are far higher than with a classic psychedelic taken alone.

The body also takes a real hit even without an interaction. DMT raises blood pressure, heart rate, and body temperature, and ayahuasca raises blood pressure too[3][4]. For someone with significant heart disease, that stimulation is a meaningful risk on its own. Ayahuasca also commonly causes vomiting, traditionally seen as part of the cleanse, which adds dehydration to the picture.

The Psychological Risks

Worth asking before an ayahuasca retreatWhat medications am I taking, and could any interact dangerously with the MAOIs in ayahuasca? Do I or my family have a history of psychosis or bipolar disorder? Is medical help reachable from where this is happening? Who is facilitating, and are they screening participants? These aren’t buzzkill questions, they’re the difference between a safe experience and a dangerous one.

Beyond the interaction danger, DMT and ayahuasca carry the psychological risks common to all classic psychedelics, shaped by their unique intensity.

Overwhelming experiences are common, by design. DMT in particular is famous for its sheer intensity, an experience so total it can feel like leaving the body or the world entirely. Ayahuasca’s long arc can include frightening passages, confronting imagery, and emotional upheaval. These can be deeply distressing in the moment. The same grounding principles that help with any hard psychedelic experience apply, and knowing how to handle an overwhelming trip is valuable preparation.

Dangerous behavior and vulnerable settings matter. With ayahuasca often taken in unfamiliar retreat settings, sometimes far from medical care, the importance of a safe environment and trustworthy facilitators is high. Impaired judgment during the experience, not the drug’s toxicity, drives most situational harm.

Psychosis risk applies here too. In rare cases, classic psychedelics can trigger persistent psychotic symptoms, with the risk concentrated in people who have a personal or family history of psychotic illness like schizophrenia[1]. That history is a strong reason to avoid DMT and ayahuasca.

The Therapeutic Research Context

Promise in research, real dangers outside itAyahuasca’s antidepressant results in a controlled trial are genuinely encouraging[5]. But those safeguards, screening, dosing, supervision, and crucially keeping participants off interacting medications, are exactly what makes research safe and what’s missing in the wild. The drug interaction danger doesn’t disappear because the science is hopeful.

Like other psychedelics, ayahuasca is being studied for mental health, and the context is worth understanding, though it’s not an endorsement of unsupervised use.

Ayahuasca has shown rapid antidepressant signals in controlled research. In a randomized, placebo-controlled trial in people with treatment-resistant depression, a single dose of ayahuasca produced significantly greater improvement than placebo, with response rates climbing over the following week[5]. It was, to the authors’ knowledge, the first controlled trial of a psychedelic in treatment-resistant depression, and it pointed to both safety in a careful setting and therapeutic promise.

The caveat is the same as for all psychedelic research. That trial used a measured dose, careful participant screening, medical supervision, and a controlled environment, none of which apply to a recreational or retreat setting, and certainly not to anyone combining the brew with antidepressants. The promising science is a reason for continued study and hope, not a green light for unsupervised use of an illegal substance.

When DMT or Ayahuasca Use Signals Something Else

Because these are not addictive drugs, compulsive use is unusual, and regular ayahuasca users studied clinically don’t show the harms of a drug problem[2]. But drug use of any kind can still point to something worth addressing.

The reasons underneath can matter more than the substance. Some people pursue psychedelics to escape pain, anxiety, or emptiness, or use them alongside substances that genuinely are addictive. If that’s the real story, the way forward is support, not shame.

Help is for the whole picture. Treatment can address the substances, the reasons underneath, and any mood or anxiety driving the use, including the depression or trauma that sometimes draws people to ayahuasca in the first place. If you’re concerned about your own use or someone else’s, or you’re combining psychedelics with drugs that do create dependence, you don’t need an addiction diagnosis to deserve help. Find people who can help you sort it out →

The honest bottom line: DMT and ayahuasca won’t hook your body, but ayahuasca’s MAOI chemistry makes drug interactions a genuine, potentially deadly hazard, never mix it with antidepressants or serotonergic drugs without medical guidance. Take the psychosis risk seriously if it applies to you, respect the physical stimulation, and reach out if drug use has started to weigh on your life.

The next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

Are DMT and ayahuasca addictive?

No. As classic psychedelics, DMT and ayahuasca are not physically addictive and carry a low potential for dependence, with no cravings, escalating use, or withdrawal[1]. The real-world evidence is unusually strong for ayahuasca: researchers formally assessed addiction severity in regular ritual users and found they didn’t show the medical or psychosocial harms typical of drugs of abuse, in fact they scored lower than non-users on alcohol use and psychiatric problems[2]. The risks worth respecting are about the experience and, for ayahuasca, a specific drug interaction, not addiction.

Why can't you mix ayahuasca with antidepressants?

Because ayahuasca contains MAO inhibitors, the compounds that let DMT work when swallowed. Combining those with substances that raise serotonin, especially antidepressants like SSRIs and SNRIs, certain other psychiatric medications, and some recreational drugs, can push serotonin to dangerous levels and cause serotonin syndrome, a potentially life-threatening emergency with agitation, high fever, muscle rigidity, racing heart, and confusion[4]. This is one of the most important and least known dangers of ayahuasca. Never combine it with antidepressants or serotonergic drugs without medical guidance, and treat those symptoms as a 911 emergency.

How long do DMT and ayahuasca last?

They’re at opposite ends of the duration spectrum despite delivering the same molecule. Smoked or injected DMT is extremely brief, in controlled research, intravenous DMT peaked within two minutes and faded by 30[3]. Ayahuasca, by contrast, stretches the experience across hours because its MAO inhibitors slow the breakdown of DMT; effects peaked between 1.5 and 2 hours in a controlled study and unfold as a long, immersive experience[4]. DMT is an intense blast; ayahuasca is a long journey.

What are the real dangers of DMT and ayahuasca?

For ayahuasca, the biggest hidden danger is the MAOI drug interaction that can cause serotonin syndrome when combined with antidepressants or other serotonergic substances[4]. Both raise blood pressure, and DMT in particular also raises heart rate and body temperature, which matters for people with heart conditions[3]. Psychologically, both can produce overwhelming, frightening experiences, and in rare cases classic psychedelics can trigger persistent psychotic symptoms in people with a personal or family history of psychotic illness[1]. Ayahuasca also commonly causes vomiting, adding dehydration risk.

Is DMT really made by the human body?

Yes. DMT (N,N-dimethyltryptamine) occurs naturally in the human body and in many plants, which is part of why it’s sometimes called ‘the spirit molecule’[3]. Its presence in mammalian biology is well established, though what role it plays there remains an open scientific question. In ayahuasca, the DMT comes from plants, made orally active by MAO-inhibiting plants brewed alongside it[4].

Does ayahuasca treat depression?

Research is promising, with an important caveat. In a randomized, placebo-controlled trial in people with treatment-resistant depression, a single dose of ayahuasca produced significantly greater improvement than placebo, with response rates climbing over the following week[5]. But that trial used a measured dose, careful screening, medical supervision, a controlled setting, and crucially kept participants off interacting medications, none of which apply to recreational or retreat use, and the MAOI interaction danger remains. The science is a reason for hope and study, not a green light for unsupervised use. You can get matched with care at /find-treatment-help/.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

5 Sources
  1. Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022). Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology, 36(3), 258-272.
  2. Fabregas, J. M., Gonzalez, D., Fondevila, S., Cutchet, M., Fernandez, X., Barbosa, P. C. R., Alcazar-Corcoles, M. A., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010). Assessment of addiction severity among ritual users of ayahuasca. Drug and Alcohol Dependence, 111(3), 257-261.
  3. Strassman, R. J., & Qualls, C. R. (1994). Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Archives of General Psychiatry, 51(2), 85-97.
  4. Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003). Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics, 306(1), 73-83.
  5. Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., et al. (2019). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine, 49(4), 655-663.
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.